Hepatocyte transplantation in acute liver failure
Bahri M. Bilir, Denis Guinette, Fritz Karrer, David A. Kumpe, Joe Krysl, Janet Stephens, Loris McGavran, Alina Ostrowska, Janette Durham – 30 December 2003 – The majority of patients with acute liver failure (ALF) die waiting for orthotopic liver transplantation (OLT). No other treatment modality is shown to improve survival. This study was conducted to assess the safety and feasibility of hepatocyte transplantation (HT) and subsequent engraftment and function of donor cells.